Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows Revision: v3.5.3, replacing Revision: v3.5.2, signaling a front-end/site version update. This change is administrative and does not modify the study data or visible content.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.5.2 was added and v3.5.0 was removed, indicating a minor software update.SummaryDifference0.0%

- Check35 days agoChange DetectedDifference0.0%

- Check57 days agoChange DetectedRevision label updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 with no visible changes to study content.SummaryDifference0.0%

- Check93 days agoChange DetectedAdded Revision: v3.4.2 to the page. Deleted the funding/operating status notice and the older Revision: v3.4.1 reference from the page.SummaryDifference0.2%

Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.